TG Therapeutics Inc vs Verizon Communications Inc — how do they compare? TG Therapeutics Inc trades at $54.06 (market cap $8.26B), while Verizon Communications Inc trades at $43.73 (market cap $181.64B). The key difference: Verizon Communications Inc is far larger — about 22× TG Therapeutics Inc's market cap, and Verizon Communications Inc pays a 6.51% dividend while TG Therapeutics Inc pays none. Which is the better fit depends on your goals.
| TGTX | VZ | |
|---|---|---|
Market Cap | $8.26B | $181.64B |
Sector | Health | Media |
52-Week High | $59.06 | $51.38 |
52-Week Low | $26.39 | $38.40 |
Enterprise Value | $8.50B | $369.14B |
Volume | — | 22,584,735 |
Dividend Yield | — | 6.51% |
Trailing returns across standard periods
Latest headlines on both assets
TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.
Read more on TGTX →Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →